Gelteq Limited (GELS)
- Previous Close
2.6600 - Open
2.4400 - Bid 2.5500 x 100
- Ask 4.1000 x 300
- Day's Range
2.4300 - 2.4993 - 52 Week Range
0.7700 - 5.5000 - Volume
97,664 - Avg. Volume
1,555,177 - Market Cap (intraday)
23.123M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.
www.gelteq.com7
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: GELS
View More
Performance Overview: GELS
Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GELS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GELS
View MoreValuation Measures
Market Cap
24.35M
Enterprise Value
26.80M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.51
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-8.04%
Return on Equity (ttm)
-21.00%
Revenue (ttm)
143.31k
Net Income Avi to Common (ttm)
-3.55M
Diluted EPS (ttm)
-0.2400
Balance Sheet and Cash Flow
Total Cash (mrq)
24.52k
Total Debt/Equity (mrq)
25.43%
Levered Free Cash Flow (ttm)
-293.77k